Cisplatin is the most important metal-based drug used in tumor therapy; however, it suffers from severe side effects and a limited spectrum of activity. Since phosphonates are known to have a selective tropism for bones and calcified tissues, we have carried on the synthesis of different platinum complexes with a phosphonate ligand. The ligand used is diethyl [(methylsulfinyl)methyl]phosphonate (SMP), which can act as an O,S-donor towards Pt. Moreover, since the sulfur atom is a stable stereogenic center, the ligand is obtained in two enantiomeric forms. The synthesised complexes have the general formula [PtL2(SMP)], in which L-2 stands for a bidentate (dimethylmalonate, 1,2-diaminocyclohexane, ethylenedi-amine) or two monodentate (chloride) ligands. The formation of a five-membered chelate ring contributes to the chemical stability of complexes with SMP, and 2D NMR experiments have allowed determination of the ring puckering, which is dependent upon the chirality of the sulfur stereocenter. For the (S) configuration at the sulfur center (free ligand), the 6 puckering of the chelate ring is favoured. Preliminary studies have shown that these compounds are stable under physiological conditions.

Synthesis and characterization of platinum(II) complexes with diethyl (methylsulfinyl)methylphosphonate: potential drugs against bone tumors

Cardellicchio C;
2004

Abstract

Cisplatin is the most important metal-based drug used in tumor therapy; however, it suffers from severe side effects and a limited spectrum of activity. Since phosphonates are known to have a selective tropism for bones and calcified tissues, we have carried on the synthesis of different platinum complexes with a phosphonate ligand. The ligand used is diethyl [(methylsulfinyl)methyl]phosphonate (SMP), which can act as an O,S-donor towards Pt. Moreover, since the sulfur atom is a stable stereogenic center, the ligand is obtained in two enantiomeric forms. The synthesised complexes have the general formula [PtL2(SMP)], in which L-2 stands for a bidentate (dimethylmalonate, 1,2-diaminocyclohexane, ethylenedi-amine) or two monodentate (chloride) ligands. The formation of a five-membered chelate ring contributes to the chemical stability of complexes with SMP, and 2D NMR experiments have allowed determination of the ring puckering, which is dependent upon the chirality of the sulfur stereocenter. For the (S) configuration at the sulfur center (free ligand), the 6 puckering of the chelate ring is favoured. Preliminary studies have shown that these compounds are stable under physiological conditions.
2004
Istituto di Chimica dei Composti OrganoMetallici - ICCOM -
ANTITUMOR-ACTIVITY
ANTICANCER DRUGS
LEAVING GROUPS
SULFOXIDES
CISPLATIN
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/171001
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 25
social impact